1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025Optimizing Intravenous Patient-Controlled Analgesia for Cancer Pain: A Randomized Controlled Trial on Adjusted Background Infusion RatesJCO ONCOLOGY PRACTICE
2025CTA-Derived Plaque Characteristics and Risk of Acute Coronary Syndrome in Patients With Coronary Artery Calcium Score of Zero: Insights From the ICONIC TrialAMERICAN JOURNAL OF ROENTGENOLOGY
2025New Algorithm for Estimating Left Ventricular Filling Pressure by EchocardiographyCIRCULATION
2025Phase I and II Clinical Studies of the STING Agonist Ulevostinag with and without Pembrolizumab in Participants with Advanced or Metastatic Solid Tumors or LymphomasCLINICAL CANCER RESEARCH
2025Impact of Tacrolimus Trough Levels at Discharge on Early Post-Kidney Transplantation Outcomes: A Nationwide Cohort Study JOURNAL OF CLINICAL MEDICINE
2025Trends in Epidemiology, Clinical Characteristics, and Outcomes of Infective Endocarditis: A 16-Year Nationwide Cohort Study in Korea JOURNAL OF KOREAN MEDICAL SCIENCE
2025Proportion of histologic component predicts lymph node metastasis risk in undifferentiated-type mucosal and submucosal gastric cancersVIRCHOWS ARCHIV
2025Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21) BMC CANCER
2025Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialCIRCULATION
2025Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study JOURNAL FOR IMMUNOTHERAPY OF CANCER
2025A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19 NATURE COMMUNICATIONS
2025Utility of Non-HLA Autoantibodies in Predicting Graft Survival After Heart TransplantationTRANSPLANTATION
2025Machine learning prediction of in-hospital mortality and external validation in patients with cardiogenic shock: the RESCUE scoreREVISTA ESPANOLA DE CARDIOLOGIA
2025Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver diseaseJOURNAL OF HEPATOLOGY
2025Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study ANNALS OF ONCOLOGY
2025Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study EUROPEAN JOURNAL OF CANCER
2025Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumabOSTEOPOROSIS INTERNATIONAL
2025Evolving roles of MET as a therapeutic target in NSCLC and beyondNATURE REVIEWS CLINICAL ONCOLOGY
2025Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy JOURNAL OF CLINICAL MEDICINE
2025An Artificial Intelligence-Enabled Electrocardiogram to Evaluate Patients With Dyspnea in the Emergency Department MAYO CLINIC PROCEEDINGS-INNOVATIONS QUALITY & OUTCOMES

Recent Submissions

Browse

Links